期刊文献+

关于产品设计缺陷与警示缺陷的法律分析 被引量:3

关于产品设计缺陷与警示缺陷的法律分析
下载PDF
导出
摘要 产品缺陷是产品责任成立的一个不可缺少的构成要件,如何认定缺陷的存在,特别是生产者已对产品的危险性进行了说明和警示的情况下,是否还存在设计缺陷,两者的关系如何确定,这些都是产品责任法实践中存在困惑的问题。本文在比较研究的基础上,指出应引入消费者期望标准和风险效益标准,确立若干可供考虑的因素,对两者进行辩证分析,以准确界定产品缺陷。 Product defection is an indispensable part of product liability. In the practice of product liability law, many complex problems exist. For example, how to define the existence of product defect, especially how to define whether design defect exists when producer has mentioned the product defect and how to define the relationship between product design defect and caution defect. On the bases of comparative analysis, this article points out: consumer anticipation standard and risk benefit standard should be applied to defining certain considerable elements and dialectic analysis of product design defect and caution defect should be made in order to define product liability precisely.
作者 周新军
出处 《广东外语外贸大学学报》 2007年第4期83-86,共4页 Journal of Guangdong University of Foreign Studies
关键词 产品责任 产品缺陷 设计缺陷 警示缺陷 product liability product defect design defect caution defect
  • 相关文献

参考文献4

  • 1[1]Blacks Law Dictionary[Z].West Publish Co.1991.990. 被引量:1
  • 2[2]Douglas A.Dysar,The Expectations of Consumes[J].Columbia Law Review,2003(Nov):825. 被引量:1
  • 3[3]Liebeck v.McDonld's Restaurants,P.T.S,Inc.(N.M.Dist.1994). 被引量:1
  • 4[4][美]P·菲利普斯.产品责任法(影印版)[M].法律出版社,1999:93. 被引量:1

同被引文献14

  • 1赵蓓,王准,宋民宪.药品警示缺陷概念分析[J].中药与临床,2013,4(2):56-58. 被引量:2
  • 2谷素红.产品警示缺陷探析[J].重庆邮电学院学报(社会科学版),2005,17(3):383-386. 被引量:2
  • 3梁亚.产品警示缺陷若干问题研究——以美国产品责任法为背景[J].时代法学,2007,5(3):54-61. 被引量:3
  • 4全国人大.中华人民共和国产品质量法(中华人民共和国主席令第33号)[S/OL].(1993-02-22)[2014-05-27].http://www.npc.gov.cn/wxzl/wxzl/2000-12/05/content_4578.htm. 被引量:1
  • 5全国人大.中华人民共和国药品管理法(中华人民共和国主席令第45号)[S/OL].(2001-02-28)[2014-05-27].http://www.sdagov.cn/WS01/CL0064/23396.html. 被引量:1
  • 6Michael W. ,Scott Pamela C. ,Hicks BEIRNE MAYNARD & PARSONS L.L.P. A Case Study of Ernst v. Merck & Co. Inc[EB/OL]. [ 2014-5-27 ]. http ://www. google, com. hk/url ? q=http ://www. thefederation, org/documents/04. - % 2520Hicks. pdf&sa=U&ei= KjtFU_6FMO-XiQe8j YCADQ&ved=0CB4QFjAA&usg= AFQjCNFwlo_hZBzRV13EASVUrJuRNhOKTg. 被引量:1
  • 7SUPREME COURT OF THE UNITED STATES .WYETH v. LEVINE [EB/OL]. (2009-03-04) [2014-05-27].http://www.supremecourt. gov/opinions/08pdf/06-1249.pdf. 被引量:1
  • 8Baker R V .Supreme Court won't disturb punitive damages award againstNovartisinAredia/ZometaCase [EB/OL].(2013-10-7) [2014- 05-27].http://blog.thomsonreuters.com/index.php/supreme-court- wont-disturb-punitive-damages-award-against-novartis-in- arediazometa-case/. 被引量:1
  • 9FDA.Federal Food, Drug, and Cosmetic Act (FD&C Act)SUBCHAPTER V Part A Sec. 352-Misbranded drugs and devices.[S/OL].(1938- 01-25) [2014-05-27].http://www.gpo.gov/fdsys/pkg/USCODE- 2010-title21/html/USCODE-2010-title2i-chap9-subchapV- partA-sec352.htm. 被引量:1
  • 10FDA.Federal Food, Drug, and Cosmetic Act (FD&C Act). SUB- CHAPTER III. Sec. 331- Prohibited acts [S/OL]. (1938-01-25) [2014-05-27].http://www.gpo.gov/fdsys/pkg/USCODE-2010- title21/html/USCODE-2010-title21-chap9-subchapIII-sec331.htm. 被引量:1

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部